These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 13790639)

  • 21. [Titers of C 3 factor of serum complement in various autoimmune diseases].
    Lehman C; Andreis M; Bennett L; Godoy G
    Rev Med Chil; 1972; 100(5):497-501. PubMed ID: 4625016
    [No Abstract]   [Full Text] [Related]  

  • 22. [ON THE LE CELL: SPECIFICITY AND POSITIVITY].
    VERRASTRO T; JAMRA M
    Rev Hosp Clin Fac Med Sao Paulo; 1964; 19():37-42. PubMed ID: 14132988
    [No Abstract]   [Full Text] [Related]  

  • 23. Alper CA, Rosen FS: Studies of the in vivo behavior of human C'3 in normal subjects and patients.
    Alper CA; Rosen FS
    J Clin Invest; 1967 Dec; 46(12):2021-34. PubMed ID: 6074005
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Agglutinating factors eluted from erythrocytes of patients with rheumatoid arthritis and patients with acquired hemolytic anemia.
    Blodgett RC; Hill RW; Mayne JG; Owen CA
    Acta Rheumatol Scand; 1967; 13(3):215-21. PubMed ID: 5299833
    [No Abstract]   [Full Text] [Related]  

  • 25. RECENT ADVANCES IN IMMUNOPATHOLOGY.
    DAVIDSOHN I
    New Physician; 1964 Jul; 13():233-7. PubMed ID: 14179201
    [No Abstract]   [Full Text] [Related]  

  • 26. Topics in clinical medicine. Complement levels in disease.
    Townes AS
    Johns Hopkins Med J; 1967 May; 120(5):337-43. PubMed ID: 6024563
    [No Abstract]   [Full Text] [Related]  

  • 27. The complement system in necrotizing angiitis of the skin. Analysis of complement component activities in serum of patients with concomitant collagen-vascular diseases.
    Soter NA; Austen KF; Gigli I
    J Invest Dermatol; 1974 Aug; 63(2):219-26. PubMed ID: 4152325
    [No Abstract]   [Full Text] [Related]  

  • 28. Anemia, serum vitamin B12, and folic acid in patients with rheumatoid arthritis, psoriatic arthritis, and systemic lupus erythematosus.
    Segal R; Baumoehl Y; Elkayam O; Levartovsky D; Litinsky I; Paran D; Wigler I; Habot B; Leibovitz A; Sela BA; Caspi D
    Rheumatol Int; 2004 Jan; 24(1):14-9. PubMed ID: 12720045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [SOME PROBLEMS OF MEDICAL METHODS IN CORTICOSTEROID THERAPY].
    KASSIRSKII Ia; MILEVSKAIA IuL
    Ter Arkh; 1964 Jan; 36():3-16. PubMed ID: 14149442
    [No Abstract]   [Full Text] [Related]  

  • 30. The effect of corticosteroid drugs on serum iron levels in systemic lupus erythematosus and rheumatoid arthritis.
    Whittingham S; Balazs ND; Mackay IR
    Med J Aust; 1967 Sep; 2(14):639-41. PubMed ID: 6058269
    [No Abstract]   [Full Text] [Related]  

  • 31. Serum concentrations of alpha tocopherol, beta carotene, and retinol preceding the diagnosis of rheumatoid arthritis and systemic lupus erythematosus.
    Comstock GW; Burke AE; Hoffman SC; Helzlsouer KJ; Bendich A; Masi AT; Norkus EP; Malamet RL; Gershwin ME
    Ann Rheum Dis; 1997 May; 56(5):323-5. PubMed ID: 9175934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IgG Fc receptors in sera from patients with rheumatoid arthritis and systemic lupus erythematosus.
    Ulvestad E; Matre R; Tønder O
    Scand J Rheumatol Suppl; 1988; 75():203-8. PubMed ID: 3238352
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum complement, rheumatoid factor, and other serum proteins in rheumatoid disease and systemic lupus erythematosus.
    ELLIS HA; FELIX-DAVIES D
    Ann Rheum Dis; 1959 Sep; 18(3):215-24. PubMed ID: 13820041
    [No Abstract]   [Full Text] [Related]  

  • 34. [Immunoglobulins and complement in systemic lupus erythematosus, rheumatoid arthritis and juvenile rheumatoid arthritis].
    Dostal Ts; Shusta A; Gana I; Bardfeld R
    Ter Arkh; 1974; 46(11):98-100. PubMed ID: 4216106
    [No Abstract]   [Full Text] [Related]  

  • 35. The influence of mean blood pressure on arterial stiffening and endothelial dysfunction in women with rheumatoid arthritis and systemic lupus erythematosus.
    Cypienė A; Dadonienė J; Rugienė R; Ryliškytė L; Kovaitė M; Petrulionienė Z; Venalis A; Laucevičius A
    Medicina (Kaunas); 2010; 46(8):522-30. PubMed ID: 20966628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pathogenesis of complement decrease in the synovial fluid in rheumatoid arthritis and disseminated lupus erythematosus].
    Peltier AP; de Sèze S
    Rev Rhum Mal Osteoartic; 1971 Jan; 38(1):61-8. PubMed ID: 5549169
    [No Abstract]   [Full Text] [Related]  

  • 37. Humoral suppression of erythropoiesis in systemic lupus erythematosus (SLE) and rheumatoid arthritis.
    Dainiak N; Hardin J; Floyd V; Callahan M; Hoffman R
    Am J Med; 1980 Oct; 69(4):537-44. PubMed ID: 7424943
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lymphocytotoxins in rheumatoid arthritis.
    Levo Y; Waisman Y; Ehrenfeld M
    Isr J Med Sci; 1980 Nov; 16(11):791-4. PubMed ID: 6969241
    [No Abstract]   [Full Text] [Related]  

  • 39. Serum anti-nuclear factor. Laboratory studies.
    WEIR DM; HOLBOROW EJ
    Ann Rheum Dis; 1962 Mar; 21(1):40-4. PubMed ID: 14005795
    [No Abstract]   [Full Text] [Related]  

  • 40. [Stepwise extraction of the blood lipids of rheumatoid arthritis and systemic lupus erythematosus patients].
    Bagirova GG
    Lab Delo; 1987; (3):215-7. PubMed ID: 2438468
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.